Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -11.71%21 EV-to-EBITDA is 1.91 as of Aug. 19, 2026. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 747 Media - Diversified companies, Haoxi Health Technology ranks better than 88.62% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Haoxi Health Technology's enterprise value is $-3.77 Mil.
Haoxi Health Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.98 Mil. Therefore, Haoxi Health Technology's EV-to-EBITDA for today is 1.91.
The historical rank and industry rank for Haoxi Health Technology's EV-to-EBITDA or its related term are showing as below:
HAO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.65 Med: -0.77 Max: 198.94
Current: 1.91
During the past 5 years, the highest EV-to-EBITDA of Haoxi Health Technology was 198.94. The lowest was -1.65. And the median was -0.77.
HAO's EV-to-EBITDA is ranked better than 88.62% of 747
companies
in the Media - Diversified industry
Industry Median: 7.05
vs HAO: 1.91
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Haoxi Health Technology (NAS:HAO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Haoxi Health Technology's PE Ratio (TTM) for today is calculated as:
Haoxi Health Technology's share price for today is $3.92.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haoxi Health Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-283.544.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Advertising Agencies subindustry, Haoxi Health Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology EV-to-EBITDA vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's EV-to-EBITDA falls into.
Haoxi Health Technology's current Enterprise Value is $-3.77 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haoxi Health Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.98 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a EV-to-EBITDA of 1.91 as of Aug. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Haoxi Health Technology. According to the industry distribution chart, Haoxi Health Technology ranks #85 out of 747 companies in the Media - Diversified industry, placing it in the top 11.4%.
Is Haoxi Health Technology's EV-to-EBITDA too high?
Haoxi Health Technology's current EV-to-EBITDA is 1.91. The Media - Diversified industry median EV-to-EBITDA is 7.05. Haoxi Health Technology's value of 1.91 is 72.9% below this industry median. Based on the distribution chart, Haoxi Health Technology ranks #85 out of 747 companies in the Media - Diversified industry, which is in the top quartile — a strong position relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's EV-to-EBITDA compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #85 out of 747 companies for EV-to-EBITDA. This places Haoxi Health Technology in the top 11% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 7.05. Haoxi Health Technology's value of 1.91 is 72.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Media - Diversified company?
The median EV-to-EBITDA among Media - Diversified companies is 7.05, based on 747 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haoxi Health Technology's current EV-to-EBITDA of 1.91 is 72.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Haoxi Health Technology. For the Media - Diversified industry, the median EV-to-EBITDA is 7.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current EV-to-EBITDA is 1.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current EV-to-EBITDA of 1.91. The current EV-to-EBITDA is 1.91 and 72.9% below the Media - Diversified industry median of 7.05. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current EV-to-EBITDA is 1.91 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
